Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development

for the, International Neonatal Consortium

Research output: Contribution to journalArticle

28 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)15-21.e1
JournalJournal of Pediatrics
Volume191
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Bronchopulmonary Dysplasia
Respiratory Insufficiency
Chronic Disease
Lung
Pharmaceutical Preparations

Keywords

  • bronchopulmonary dysplasia
  • chronic lung disease
  • long term outcomes
  • respiratory failure

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Chronic Pulmonary Insufficiency of Prematurity : Developing Optimal Endpoints for Drug Development. / for the; International Neonatal Consortium.

In: Journal of Pediatrics, Vol. 191, 01.12.2017, p. 15-21.e1.

Research output: Contribution to journalArticle

for the ; International Neonatal Consortium. / Chronic Pulmonary Insufficiency of Prematurity : Developing Optimal Endpoints for Drug Development. In: Journal of Pediatrics. 2017 ; Vol. 191. pp. 15-21.e1.
@article{15452c12177f495caa872de0d8ecdfcb,
title = "Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development",
keywords = "bronchopulmonary dysplasia, chronic lung disease, long term outcomes, respiratory failure",
author = "{for the} and {International Neonatal Consortium} and Steinhorn, {Robin H} and Davis, {Jonathan M.} and Wolfgang G{\"o}pel and Alan Jobe and Steven Abman and Matthew Laughon and Eduardo Bancalari and Judy Aschner and Roberta Ballard and Anne Greenough and Linda Storari and Merran Thomson and Ariagno, {Ronald L.} and Laura Fabbri and Turner, {Mark A.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.jpeds.2017.08.006",
language = "English (US)",
volume = "191",
pages = "15--21.e1",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Chronic Pulmonary Insufficiency of Prematurity

T2 - Developing Optimal Endpoints for Drug Development

AU - for the

AU - International Neonatal Consortium

AU - Steinhorn, Robin H

AU - Davis, Jonathan M.

AU - Göpel, Wolfgang

AU - Jobe, Alan

AU - Abman, Steven

AU - Laughon, Matthew

AU - Bancalari, Eduardo

AU - Aschner, Judy

AU - Ballard, Roberta

AU - Greenough, Anne

AU - Storari, Linda

AU - Thomson, Merran

AU - Ariagno, Ronald L.

AU - Fabbri, Laura

AU - Turner, Mark A.

PY - 2017/12/1

Y1 - 2017/12/1

KW - bronchopulmonary dysplasia

KW - chronic lung disease

KW - long term outcomes

KW - respiratory failure

UR - http://www.scopus.com/inward/record.url?scp=85033676473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033676473&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2017.08.006

DO - 10.1016/j.jpeds.2017.08.006

M3 - Article

C2 - 29173299

AN - SCOPUS:85033676473

VL - 191

SP - 15-21.e1

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

ER -